MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds

thought leadership

Increase your influence in early pipeline planning: why earlier value assessment of your assets through a payer lens makes a difference.


Please provide your details to watch this free webinar

As aspiring treatments begin their journey through clinical development programs, a range of decisions need to be made, many of which can ultimately impact market access potential.

Evolving treatment landscapes and advances in scientific and medical innovation increase the pressure on payers, and manufacturers need to be making well-planned and informed decisions about pipeline assets in that context.

We already know that it is never too early to start assessing the value of an asset through the payer lens, but how do we understand and translate any potential opportunities and risks in realizing the value of an asset in a way that can be easily understood by cross-functional stakeholders?

Watch this webinar to understand what payer-relevant challenges and opportunities may present themselves for early pipeline assets and discover ways of making those insights drive more positive market access outcomes.

Discussion points

  • Why are increasing pressures in the regulatory and policy arena, coupled with increasingly complex treatment pathways, enhancing the focus on demonstrating value for new assets?
  • When payers are under pressure to make decisions based on the assets value, how do you establish and communicate value effectively?
  • How can you “right size” your approach to market access by identifying risks and opportunities for an asset early in the clinical development lifecycle?

Learning aims

  • Examine how external factors are driving the increasing need to evaluate value potential for your assets in an early pipeline.
  • Review examples of how early value assessment can identify critical issues for your asset.
  • Understand how a robust value assessment framework enables your teams to align on value risks and opportunities before committing to later-stage clinical development plans.
  • Discover why your industry peers are engaging in value assessment across early pipeline assets, and the confidence this brings to successfully inform key development milestones and launch strategy.

Duration: 30 minutes.

We care about your privacy

By clicking "Accept all cookies", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Manage my preferences

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Avalere Health website, such as the pages you visit.

For more information, check the cookie statement


Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.